On ECHEMI
Home > Drugs > dementia
dementia
Dementia refers to the decline and impairment of acquired occupational and social activity skills, cognitive decline, memory loss, visual-spatial skill impairment, loss of orientation, calculation, and judgment, and the emergence of personality, emotional, and behavioral changes in a progressive and aggravating process. The cause of Pick's disease is also unclear, and it may be a dominant genetic disease with multiple gene abnormalities. The pathology of Pick's disease is completely different from that of Alzheimer's disease. It is mainly characterized by localized cortical atrophy, and Pick's cells and Pick's bodies can be found. The disease begins with progressive dementia in middle age. It is a slow-onset personality change and social decline in the early stage, leading to a decline in intelligence, memory, and language function. In the late stage, it may manifest as apathy, euphoria, and occasional extrapyramidal symptoms.
  • Site of disease:

    Brain
  • Infectious :

    Not contagious
  • Frequent population:

    Elderly Group
  • Related symptoms:

    spatial perception disorder cognitive dysfunction recent amnesia memory disorder memory disorder
  • Concurrent disease:

Related Drugs
Nicergoline Tablets
Indication: 1. Improve low desire and emotional disorders (slow reaction, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.) caused by cerebral arteriosclerosis and sequelae of cerebral stroke. 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation). It is also suitable for vascular dementia, especially in the early stage of treatment, it can improve cognition, memory, etc., and can reduce the severity of the disease.
Manufacturer:

Viatris Pharmaceuticals (DALIAN) Co., Ltd.

Nicergoline Tablets
Indication: It is used for acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, and other symptoms of poor peripheral circulation). It is also suitable for vascular dementia, especially in the early stage of treatment, it can improve cognition, memory, etc. and reduce the severity of the disease.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:

Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.

Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:

Hebei Zhitong Biopharmaceutical Co., Ltd.

Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:

Guangdong Sunho Pharmaceutical Co., Ltd.

Ethyl Cysteine for Injection
Indication: Used for cerebral blood perfusion imaging of various cerebrovascular diseases (infarction, hemorrhage, transient ischemic attack, etc.), epilepsy, dementia, brain tumors and other diseases.
Manufacturer:

Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory

Technetium [99mTc] ethyl cysteate injection
Indication: Used for cerebral blood perfusion imaging of various cerebrovascular diseases (infarction, hemorrhage, transient ischemic attack, etc.), epilepsy, dementia, brain tumors and other diseases.
Manufacturer:

Shanghai Xinke Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.